Mirna Therapeutics, Inc. 4
4 · Mirna Therapeutics, Inc. · Filed Oct 6, 2015
Insider Transaction Report
Form 4
Winkler Matthew
Director
Transactions
- Conversion
Common Stock
2015-10-05+40,281→ 42,626 total(indirect: See Footnote) - Other
Common Stock
2015-10-06+8,408→ 51,034 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2015-10-05−134,958→ 0 total→ Common Stock (134,958 underlying) - Conversion
Series C Preferred Stock
2015-10-05−235,899→ 0 total→ Common Stock (235,899 underlying) - Conversion
Series C Preferred Stock
2015-10-05−40,281→ 0 total(indirect: See Footnote)→ Common Stock (40,281 underlying) - Conversion
Common Stock
2015-10-05+187,277→ 586,592 total - Conversion
Common Stock
2015-10-05+2,345→ 2,345 total(indirect: See Footnote) - Other
Common Stock
2015-10-06+8,408→ 51,034 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2015-10-05−2,345→ 0 total(indirect: See Footnote)→ Common Stock (2,345 underlying) - Conversion
Series A Preferred Stock
2015-10-05−2,345→ 0 total(indirect: See Footnote)→ Common Stock (2,345 underlying) - Conversion
Series B Preferred Stock
2015-10-05−28,458→ 0 total→ Common Stock (28,458 underlying) - Conversion
Series C Preferred Stock
2015-10-05−40,281→ 0 total(indirect: See Footnote)→ Common Stock (40,281 underlying) - Conversion
Common Stock
2015-10-05+134,958→ 134,958 total - Conversion
Common Stock
2015-10-05+28,458→ 163,416 total - Conversion
Common Stock
2015-10-05+2,345→ 2,345 total(indirect: See Footnote) - Conversion
Common Stock
2015-10-05+2,345→ 2,345 total(indirect: See Footnote) - Other
Common Stock
2015-10-06+62,582→ 649,174 total - Conversion
Common Stock
2015-10-05+235,899→ 399,315 total - Conversion
Common Stock
2015-10-05+40,281→ 42,626 total(indirect: See Footnote) - Conversion
Common Stock
2015-10-05+40,281→ 42,626 total(indirect: See Footnote) - Other
Common Stock
2015-10-06+8,408→ 51,034 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2015-10-05−2,345→ 0 total(indirect: See Footnote)→ Common Stock (2,345 underlying) - Conversion
Series C Preferred Stock
2015-10-05−40,281→ 0 total(indirect: See Footnote)→ Common Stock (40,281 underlying) - Conversion
Series D Preferred Stock
2015-10-05−187,277→ 0 total→ Common Stock (187,277 underlying)
Footnotes (7)
- [F1]Each share of Series A, Series B, Series C and Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
- [F2]The shares are held by the Daniel Winkler 2000 Trust.
- [F3]The shares are held by the John Winkler 2000 Trust.
- [F4]The shares are held by the Joshua Winkler 2000 Trust.
- [F5]The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C and Series D Preferred Stock of the Company.
- [F6]The expiration date is not relevant to the conversion of these securities.
- [F7]Due to a clerical error, the Reporting Person's Form 3 which previously reported the holding of these shares understated his total by one (1) share.